SKI Market

A+| A| A-|

Indian Indices

Sensex

73,918.76 394.50
( 0.54%)

Global Indices

Nasdaq

50,884.98 77.97
(0.15%)

Dow Jones

7,407.31 -19.42
(-0.26%)

Hang Seng

65,160.26 1,135.66
(1.77%)

Nikkei 225

10,242.24 -130.96
(-1.26%)

Forex

USD-INR

95.22 -0.51
(-0.53%)

EUR-INR

109.67 -1.54
(-1.39%)

GBP-INR

126.98 -1.60
(-1.25%)

JPY-INR

0.59 0.00
(-0.77%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lupin Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500257

INE326A01037

659.0470742

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LUPIN

17.16

103490.01

EPS(TTM)

Face Value()

Div & Yield %

131.91

0.8

Back

dhatre udyog ltd

Wanbury standalone net profit rises 7.11% in the March 2026 quarter

Jun 01,2026

Net profit of Wanbury rose 7.11% to Rs 21.70 crore in the quarter ended March 2026 as against Rs 20.26 crore during the previous quarter ended March 2025. Sales declined 4.31% to Rs 164.58 crore in the quarter ended March 2026 as against Rs 172.00 crore during the previous quarter ended March 2025.

For the full year,net profit rose 116.61% to Rs 66.13 crore in the year ended March 2026 as against Rs 30.53 crore during the previous year ended March 2025. Sales rose 8.47% to Rs 650.27 crore in the year ended March 2026 as against Rs 599.51 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	164.58	172.00	-4	650.27	599.51	8
OPM %	18.13	17.23	-	16.42	12.73	-
PBDT	21.99	22.43	-2	77.71	42.86	81
PBT	18.76	19.06	-2	63.40	29.55	115
NP	21.70	20.26	7	66.13	30.53	117

73,918.76 394.50 ( 0.54%)

50,884.98 77.97 (0.15%)

7,407.31 -19.42 (-0.26%)

65,160.26 1,135.66 (1.77%)

10,242.24 -130.96 (-1.26%)

95.22 -0.51 (-0.53%)

109.67 -1.54 (-1.39%)

126.98 -1.60 (-1.25%)

0.59 0.00 (-0.77%)